drugset / Trial / NCT07692165
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
RandomizedParallel-groupOpen-labelTreatment
Summary
A Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants with Active Ulcerative Colitis. The study aims to evaluate the safety, efficacy, pharmacokinetic (PK) characteristics, pharmacodynamic (PD) characteristics of INT-210 in participants with active ulcerative colitis (UC).
Timeline
- Start
- 2026-06-11
- Primary completion
- 2028-06
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INT-210 | Unknown | 200 mg | Oral |
| Subject | INT-210 | Unknown | 400 mg | Oral |